Estrogen receptor-beta prevents cardiac fibrosis.
Development of cardiac fibrosis portends the transition and deterioration from hypertrophy to dilation and heart failure. Here we examined how estrogen blocks this important development. Angiotensin II (AngII) and endothelin-1 induce cardiac hypertrophy and fibrosis in humans. and we find that these agents directly stimulate the transition of the cardiac fibroblast to a myofibroblast. AngII and endothelin-1 stimulated TGFβ1 synthesis in the fibroblast, an inducer of fibrosis that signaled via c-jun kinase to Sma- and Mad-related protein 3 phosphorylation and nuclear translocation in myofibroblasts. As a result, mesenchymal proteins fibronectin and vimentin were produced, as were collagens I and III, the major forms found in fibrotic hearts. 17β-Estradiol (E2) or dipropylnitrile, an estrogen receptor (ER)β agonist, comparably blocked all these events, reversed by estrogen receptor (ER)β small interfering RNA. E2 and dipropylnitrile signaling through cAMP and protein kinase A prevented myofibroblast formation and blocked activation of c-jun kinase and important events of fibrosis. In the hearts of ovariectomized female mice, cardiac hypertrophy and fibrosis were induced by AngII infusion and prevented by E2 administration to wild type but not ERβ knockout rodents. Our results establish the cardiac fibroblast as an important target for hypertrophic/fibrosis-inducing peptides the actions of which were mitigated by E2/ERβ acting in these stromal cells.
Pedram
Ali
A
Medical Service (111-I), Department of Veterans Affairs Medical Center, 5901 East 7th Street, Long Beach, California 90822, USA.
Razandi
Mahnaz
M
O'Mahony
Fiona
F
Lubahn
Dennis
D
Levin
Ellis R
ER
D000818:Animals; D000242:Cyclic AMP / Q000096:biosynthesis; D004958:Estradiol / Q000494:pharmacology; D047629:Estrogen Receptor beta / Q000378:metabolism*; D005260:Female; D005355:Fibrosis; D051379:Mice; D008954:Models, Biological; D009206:Myocardium / Q000378:metabolism* / Q000473:pathology*; D058628:Myofibroblasts / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D014176:Protein Biosynthesis / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction / Q000187:drug effects; D051785:Smad Proteins / Q000378:metabolism
D047629:Estrogen Receptor beta; D051785:Smad Proteins; D004958:Estradiol; D000242:Cyclic AMP
J Hypertens. 2001 Feb;19(2):269-78
11212970
N Engl J Med. 1991 Sep 12;325(11):756-62
1870648
Mol Pharmacol. 2006 Dec;70(6):1992-2003
16959941
JAMA. 2002 Jul 17;288(3):321-33
12117397
EMBO J. 1999 Mar 1;18(5):1345-56
10064600
Echocardiography. 2007 Apr;24(4):374-84
17381646
Can J Cardiol. 2002 Dec;18(12):1331-9
12518185
JAMA. 2007 Apr 4;297(13):1465-77
17405972
J Biol Chem. 2007 Aug 3;282(31):22278-88
17535799
World J Gastroenterol. 2007 Aug 28;13(32):4295-305
17708600
Cardiovasc Res. 2008 Mar 1;77(4):774-81
18056768
Int J Exp Pathol. 2004 Apr;85(2):47-64
15154911
Mol Endocrinol. 2006 Sep;20(9):1996-2009
16645038
Lab Invest. 2005 Jul;85(7):862-73
15856048
Circulation. 2005 Nov 8;112(19):2959-65
16260635
Brain Res. 2010 Apr 23;1327:47-55
20149783
Circulation. 2001 Jan 23;103(3):435-41
11157697
N Engl J Med. 2000 Aug 24;343(8):522-9
10954759
Endocrinology. 2008 Jul;149(7):3361-9
18372323
Circ Res. 2002 Dec 13;91(12):1103-13
12480810
J Submicrosc Cytol Pathol. 2005 Aug;37(2):109-204
16335592
J Biol Chem. 2003 Sep 26;278(39):36981-4
12881512
Expert Rev Cardiovasc Ther. 2009 Jun;7(6):703-13
19505285
J Biol Chem. 2010 Apr 9;285(15):11638-51
20142324
Circ Res. 1998 Apr 6;82(6):666-76
9546375
Proc Natl Acad Sci U S A. 2006 May 2;103(18):7165-9
16636272
Cell Signal. 2007 Feb;19(2):428-38
16949794
J Mol Cell Cardiol. 2003 Jan;35(1):59-70
12623300
Am J Physiol Lung Cell Mol Physiol. 2007 Feb;292(2):L405-13
17028262
J Biol Chem. 2003 Jan 24;278(4):2701-12
12421825
Epidemiology. 2008 Nov;19(6):766-79
18854702
N Engl J Med. 2007 Oct 25;357(17):1767-8
17960018
Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H469-76
15374829
Methods Enzymol. 2002;344:58-69
11771412
Nature. 2002 Mar 21;416(6878):334-8
11907581
Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1524-30
16627800
N Engl J Med. 1985 Oct 24;313(17):1044-9
4047106
Am J Physiol Cell Physiol. 2006 Mar;290(3):C661-8
16469861
Cardiovasc Res. 2007 May 1;74(2):196-206
17376414
Cell. 1998 Apr 17;93(2):215-28
9568714
J Cell Physiol. 2007 Nov;213(2):540-51
17541957
Endocrinology. 2010 Apr;151(4):1837-45
20176721
Science. 2002 Jan 18;295(5554):505-8
11799247
Prev Med. 1991 Jan;20(1):47-63
1826173
Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):437-42
15625103
N Engl J Med. 2007 Jun 21;356(25):2591-602
17582069
Med Clin North Am. 2004 Jan;88(1):83-97
14871052
Science. 2007 Jul 6;317(5834):121-4
17615358
J Biol Chem. 2005 Jul 15;280(28):26339-48
15899894
Curr Opin Nephrol Hypertens. 2004 Mar;13(2):197-204
15202614
J Clin Invest. 2007 Mar;117(3):568-75
17332884